Evidence map›Paper›PMID 27390125›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2016

Editorial: Subduing Lupus: Can Preclinical Autoimmune Disease Be Arrested?

Heather M Berens-Norman, Susan A Boackle

Abstract readEditorialComment
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. SLE: reconciling heterogeneity.Lupus science & medicine · 2019
    Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Heather M Berens-NormanUniversity of Colorado Denver School of Medicine, Aurora.
Susan A BoackleUniversity of Colorado Denver School of Medicine, Aurora. susan.boackle@ucdenver.edu.

Funding

Research Training in Rheumatology INCLUDE Down Syndrome SupplementT32AR007534 · NIAMS · UNIVERSITY OF COLORADO DENVER · PI Kristine A. Kuhn · 1986 to 2026
$6.1M
Analysis of Lupus Susceptibility Genes for Treatment and Prevention of DiseaseK24AI078004 · NIAID · UNIVERSITY OF COLORADO DENVER · PI BOACKLE, SUSAN A. · 2010 to 2014
$739k
Complement Receptor 2 as a Biomarker for Systemic Lupus ErythematosusR21AI070304 · NIAID · UNIVERSITY OF COLORADO DENVER · PI BOACKLE, SUSAN A. · 2006 to 2007
$411k
NIAID NIH HHS K24 AI078004NIAID NIH HHS R21 AI070304NIAMS NIH HHS T32 AR007534
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Autoimmune DiseasesLupus Erythematosus, SystemicHumans

Identifiers

PMID27390125
PMCPMC5042838

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.